Skip to main content
PLIANT THERAPEUTICS, INC. logo

PLIANT THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · PLRX ISIN · US7291391057 LEI · 5493002Q5LITR7VHZH02 US Professional, scientific and technical activities
Open in API
Filings indexed 403 across all filing types
Latest filing 2021-01-27 Director's Dealing
Country US United States of America
Listing US PLRX

About PLIANT THERAPEUTICS, INC.

https://pliantrx.com/

Pliant Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of fibrosis and related diseases. The company leverages its expertise in integrin biology to create tissue-specific treatments. Its therapeutic approach centers on modulating integrin activity and inhibiting TGF-β1 signaling, which are key molecular drivers of fibrosis. Pliant utilizes its proprietary discovery platform to advance a pipeline of integrin-based product candidates, aiming to provide safer and more effective therapies for patients.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2021-01-27 English
FORM 4 SUBMISSION
Director's Dealing
2021-01-27 English
FORM 4 SUBMISSION
Director's Dealing
2021-01-16 English
FORM 4 SUBMISSION
Director's Dealing
2021-01-14 English
FORM 3 SUBMISSION
Director's Dealing
2021-01-14 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated January 12, 2021, by Pliant Therapeutics, Inc. The key content is the appointment of a new director, David Pyott, to the Board of Directors, including details about his qualifications, option grant, and indemnification agreement. The document focuses on changes in the company's board of directors, which aligns with the category for announcements of changes in the company's board or senior management. There is no financial data or report content, so it is not an annual or interim report. The document is not a proxy statement or voting result announcement. Therefore, the appropriate classification is Board/Management Information (MANG). The document length and detail support a high confidence in this classification.
2021-01-13 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.